Next Article in Journal
Deep Cerebellar Transcranial Direct Current Stimulation of the Dentate Nucleus to Facilitate Standing Balance in Chronic Stroke Survivors—A Pilot Study
Previous Article in Journal
Cortical Oscillations during Gait: Wouldn’t Walking Be So Automatic?
Opinion

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease

Massachusetts College of Pharmacy and Health Science University, Boston, MA 02115, USA
*
Author to whom correspondence should be addressed.
Brain Sci. 2020, 10(2), 93; https://doi.org/10.3390/brainsci10020093
Received: 23 January 2020 / Revised: 5 February 2020 / Accepted: 5 February 2020 / Published: 10 February 2020
(This article belongs to the Section Molecular and Cellular Neuroscience)
Alzheimer’s disease (AD) is characterized by deposition and accumulation of amyloid-β (Aβ) and its corresponding plaques within the brain. Although much debate exists whether these plaques are the cause or the effect of AD, the accumulation of Aβ is linked with the imbalance between the production and clearance of Aβ. The receptor for advanced glycation endproducts (RAGE) facilitates entry of free Aβ from the peripheral stream. Conversely, lipoprotein receptor-related protein 1 (LRP1), located in the abluminal side at the blood–brain barrier mediates the efflux of Aβ. Research on altering the rates of clearance of Aβ by targeting these two pathways has been extensively study. Additionally, a cerebrospinal fluid (CSF) circulation assistant device has also been evaluated as an approach to increase solute concentration in the CSF via mechanical drainage, to allow for removal of Aβ from the brain. Herein, we provide a brief review of these approaches that are designed to re-establish a homeostatic Aβ balance in the brain. View Full-Text
Keywords: Alzheimer’s disease; amyloid-β; lipoprotein receptor-related protein 1; receptor for advanced glycation endproducts; cerebrospinal fluid Alzheimer’s disease; amyloid-β; lipoprotein receptor-related protein 1; receptor for advanced glycation endproducts; cerebrospinal fluid
Show Figures

Figure 1

MDPI and ACS Style

Kim, D.E.; Priefer, R. Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease. Brain Sci. 2020, 10, 93. https://doi.org/10.3390/brainsci10020093

AMA Style

Kim DE, Priefer R. Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease. Brain Sciences. 2020; 10(2):93. https://doi.org/10.3390/brainsci10020093

Chicago/Turabian Style

Kim, Dong E., and Ronny Priefer. 2020. "Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease" Brain Sciences 10, no. 2: 93. https://doi.org/10.3390/brainsci10020093

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop